C14H14CdI 2 N 6 , triclinic, P1 (no. 2), a = 7.9247(5) Å,
and a list of the atoms including atomic coordinates and displacement parameters.
Source of materials
All the reagents were obtained from commercial sources. A mixture of CdI 2 (0.02 g, 0.05 mmol), 1H-benzimidazol-2-amine (0.02 g, 0.15 mmol), N,N-dimethylformamide (2 mL) and methanol (2 mL) was placed in a 25 mL Teflon-lined stainless steel vessel and heated at 120°C for 72 h. After the mixture cooled to room temperature at 5°C·h −1 , crystals of the title complex were obtained.
Comment
In the recent years, the benzimidazoles play an important role in their intriguing structures and potential applications in anticancer acticities [4] [5] [6] [7] [8] [9] [10] . The 2-position of benzimidazole was replaced by an amino group to get one ligand which has more coordinate sites and different coordinate modes. So we used 1H-benzimidazol-2-amine as organic ligand to react with CdI 2 and obtained a new complex. The asymmetric unit contains one Cd(II) ions, two I − anions and two 1H-benzimidazol-2-amines. Each Cd(II) is coordinated by two iodines (I1,I2) and two nitrogens (N1,N4) from two imidazole rings of the ligands, forming a distorted tetrahedral coordination geometry. The Cd-I bond lengths of 2.7183(4) Å and 2.7367(4) Å and Cd-N bond lengths of 2.218(3) Å and 2.252(3) Å are similar to those reported in [Cd(2-SC5H 3 NH-3-SiMe 3 )I 2 ] 2 and [Cd 2 (H 1/2 C4BIm) 2 (CH 3 COO)]n(H 3 btc = 1,3,5-benzenetricarboxylic acid) [11] [12] [13] . The angles around Cd(II) ion range from 100.59(11)°to 112.587(13)°. Some 
